BMC Cancer

Papers
(The H4-Index of BMC Cancer is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up189
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma170
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol150
Clinical benefits of enhanced 3D-NEVERview sequence in MRI simulation for nasopharyngeal carcinoma patients received radiotherapy135
The mortality rate of people with cancer judged to have a limited life expectancy by physicians performing work disability assessments in the Netherlands: a retrospective cohort study89
Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis74
Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting74
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis74
α-L-fucosidase isoenzymes (FUCA1/FUCA2) as prognostic markers in gliomas: a comprehensive study69
Analysis of characteristics of peripheral blood lymphocytes in endometrial carcinoma: a single-center study based on five-year clinical data69
Age-related differences in adjuvant chemotherapy use and outcomes in stage II colon cancer: a retrospective cohort study67
Safety and feasibility of liver resection including major hepatectomy for geriatric patients with hepatocellular carcinoma: a retrospective observational study66
PCBP1-AS1 facilitates liver metastasis in pancreatic cancer by modulating miR-125b-5p in Tumor-derived exosomes to target TNFAIP362
Assessing the performance of QLQ-C30 in predicting all-cause mortality in community cancer patients61
Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer61
Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study59
Effectiveness of axicabtagene ciloleucel versus conventional treatments as first-line therapy for high-risk large B-cell lymphoma: an external comparator study59
Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation59
Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients58
MTF1 genetic variants are associated with lung cancer risk in the Chinese Han population58
SOX4 enhances tumor progression and cisplatin resistance in orthotopic mouse xenograft model of head and neck squamous cell carcinoma57
PReCedeNT trial: Phase III randomized-controlled trial of Lutetium − 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gast55
Overexpression of COL10A1 in extracellular matrix predicts poor outcome and promotes ovarian cancer progression54
Azacytidine treatment affects the methylation pattern of genomic and cell-free DNA in uveal melanoma cell lines54
Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center52
MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts51
Gross recurrent laryngeal nerve invasion by extranodal extension in thyroid carcinoma51
Prediction models of breast cancer molecular subtypes based on multimodal ultrasound and clinical features50
Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT0498309549
Identification of alternative lengthening of telomeres-related genes prognosis model in hepatocellular carcinoma49
Prognostic value of PSA kelim score in high-volume mCSPC patients treated with abiraterone or enzalutamide: a single-center retrospective study49
Identification and verification of an eight-gene prognostic signature for colorectal cancer based on tumor-associated macrophages48
Tumor-Infiltrating lymphocyte dynamics as biomarkers of neoadjuvant treatment response in luminal breast cancer48
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial48
Cancer risk in persons with new-onset anaemia: a population-based cohort study in Denmark48
Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma48
Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis48
Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL448
Alcohol consumption and cancer incidence in women: interaction with smoking, body mass index and menopausal hormone therapy48
Tertiary lymphoid structures associate with improved survival in early oral tongue cancer48
High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinoma47
Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a mu47
L-arginine dependence of breast cancer – molecular subtypes matter.47
Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p/PTEN signaling46
Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study46
The levels of plasma MiR-9 and MiR-106a are associated with the development of peritoneal carcinomatosis in patients with gastric cancer45
Ten-year follow-up of atypical small acinar hyperplasia cases diagnosed by initial prostate biopsy45
Beta-Blockers and mortality in patients with malignancy and cardiovascular disease: an analysis of the MIMIC-IV database45
The G8 tool for screening malnutrition before GLIM in geriatric cancer patients45
0.050424098968506